Organization
Yan Bi
1 clinical trial
Clinical trial
A Multicentric, Prospective, Randomized Study Evaluating the Improvement of Renal Function Outcomes With Dorzagliatin in Patients With Type 2 Diabetes Mellitus With Early Kidney Injury.Status: Not yet recruiting, Estimated PCD: 2025-05-31